The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-κB pathway
Abstract
Rheumatoid arthritis (RA) is an autoimmune disease of the joints characterized by synovial hyperplasia and chronic inflammation. Fibroblast-like synoviocytes (FLS) play a central role in RA initiation, progression, and perpetuation. Prior studies showed that sirtuin 1 (SIRT1), a deacetylase participating in a broad range of transcriptional and metabolic regulations, may impact cell proliferation and inflammatory responses. However, the role of SIRT1 in RA–FLS was unclear. Here, we explored the effects of SIRT1 on the aggressiveness and inflammatory responses of cultured RA-FLS. SIRT1 expression was significantly lower in synovial tissues and FLS from RA patients than from healthy controls. Overexpression of SIRT1 significantly inhibited RA-FLS proliferation, migration, and invasion. SIRT1 overexpression also significantly increased RA-FLS apoptosis and caspase-3 and -8 activity. Focusing on inflammatory phenotypes, we found SIRT1 significantly reduced RA-FLS secretion of TNF-α, IL-6, IL-8, and IL-1β. Mechanistic studies further revealed SIRT1 suppressed NF-κB pathway by reducing p65 protein expression, phosphorylation, and acetylation in RA-FLS. Our results suggest SIRT1 is a key regulator in RA pathogenesis by suppressing aggressive phenotypes and inflammatory response of FLS. Enhancing SIRT1 expression or function in FLS could be therapeutic beneficial for RA by inhibiting synovial hyperplasia and inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Down-regulation of lncRNA-GAS5 during RA leads to the up-regulation of miR-223-3p and down-regulation of Sirt1.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [104]
In the citing paper
“It decreases the secretion of TNF-α, IL-6, IL-8, and IL-1β and reduces RA-FLSC apoptosis, hence slowing RA progression 82, 104.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [104]
In the citing paper
“Sirt1 is also a target gene of miR-223-3p, and lncRNA-GAS5 is a molecular sponge for miR-223-3p 82, 104.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB
Chen, L., Mu, Y., & Greene, W. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf660 · Cited by 827
Zu, Y., Liu, L., Lee, M. Y. K., Xu, C., Liang, Y., Man, R. Y., Vanhoutte, P. M., & Wang, Y. (2010) · Circulation Research · doi:10.1161/circresaha.109.215483 · Cited by 303
Research works printed but not linked: 35
- Firestein, 2003, Evolving concepts of rheumatoid arthritis, Nature, 423, 356, 10.1038/nature01661 · DOI · Paper page
- Brooks, 2001, Report of the sixth joint WHO/ILAR task force meeting on rheumatic diseases, 16 January 2000, Geneva, Switzerland, J. Rheumatol., 28, 2540
- Yu, 2018, Current status of rheumatoid arthritis registries and prevalence of remission, Zhonghua Nei Ke Za Zhi, 57, 175
- Bartok, 2010, Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis, Immunol. Rev., 233, 233, 10.1111/j.0105-2896.2009.00859.x · DOI · Paper page
- Ding, 2014, The cytokine homeostasis was regulated by overexpression of SIRT1 in collagen-induced arthritis mice, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 30, 1034
- Woo, 2016, Myeloid deletion of SIRT1 suppresses collagen-induced arthritis in mice by modulating dendritic cell maturation, Exp. Mol. Med., 48, e221, 10.1038/emm.2015.124 · DOI
- Qu, 2018, SIRT1 suppresses high glucose and palmitate-induced osteoclast differentiation via deacetylating p66Shc, Mol. Cell. Endocrinol., 10.1016/j.mce.2018.02.015 · DOI
- Park, 2015, Suppression of RANKL-induced osteoclast differentiation by cilostazol via SIRT1-induced RANK inhibition, Biochim. Biophys. Acta, 1852, 2137, 10.1016/j.bbadis.2015.07.007 · DOI
- Yan, 2016, MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis, Int. J. Mol. Med., 38, 201, 10.3892/ijmm.2016.2618 · DOI · Paper page
- Zimmermann, 2001, Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture–primary culture cells markedly differ from fourth-passage cells, Arthritis Res., 3, 72, 10.1186/ar142 · doi:10.1186/ar142
- Suzuki, 2012, SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice, Oncol. Rep., 27, 1726
- Byles, 2012, SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis, Oncogene, 31, 4619, 10.1038/onc.2011.612 · DOI · Paper page
- Nakane, 2012, Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells, Int. J. Urol., 19, 71, 10.1111/j.1442-2042.2011.02888.x · DOI
- Tang, 2010, Sirt1 and cell migration, Cell Adh. Migr., 4, 163, 10.4161/cam.4.2.10972 · DOI
- Ganesan, 2017, Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions, Int. Rev. Immunol., 36, 20, 10.1080/08830185.2016.1269175 · DOI
- Vachharajani, 2016, Sirtuins Link Inflammation and Metabolism, J. Immunol. Res., 2016, 8167273, 10.1155/2016/8167273 · DOI · Paper page
- Rathbone, 2009, Sirt1 increases skeletal muscle precursor cell proliferation, Eur. J. Cell Biol., 88, 35, 10.1016/j.ejcb.2008.08.003 · DOI
- Kabra, 2009, SirT1 is an inhibitor of proliferation and tumor formation in colon cancer, J. Biol. Chem., 284, 18210, 10.1074/jbc.M109.000034 · DOI
- Audrito, 2011, Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network, Cancer Res., 71, 4473, 10.1158/0008-5472.CAN-10-4452 · DOI · Paper page
- Li, 2015, Overexpression of SIRT1 induced by resveratrol and inhibitor of miR-204 suppresses activation and proliferation of microglia, J. Mol. Neurosci., 56, 858, 10.1007/s12031-015-0526-5 · DOI
- Moore, 2013, SIRT1 represses estrogen-signaling, ligand-independent ERalpha-mediated transcription, and cell proliferation in estrogen-responsive breast cells, J. Endocrinol., 216, 273, 10.1530/JOE-12-0102 · DOI
- Cho, 2012, SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of beta-catenin, Biochem. Biophys. Res. Commun., 423, 270, 10.1016/j.bbrc.2012.05.107 · DOI
- Jin, 2011, The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation, Hepatology, 54, 989, 10.1002/hep.24471 · DOI
- Yang, 2013, SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-kappaB/Cyclin D1 signaling, Mol. Cancer Res., 11, 1497, 10.1158/1541-7786.MCR-13-0214 · DOI
- Kok, 2013, Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling, Arthritis Rheum., 65, 639, 10.1002/art.37807 · DOI
- Niederer, 2011, SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance, Ann. Rheum. Dis., 70, 1866, 10.1136/ard.2010.148957 · DOI · Paper page
- Peng, 2016, Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of microRNAs 140-3p and 140-5p, Arthritis Rheumatol., 68, 370, 10.1002/art.39446 · DOI
- Nakayama, 2012, Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner, Rheumatol. Int., 32, 151, 10.1007/s00296-010-1598-8 · DOI
- Jin, 2007, Cytoplasm-localized SIRT1 enhances apoptosis, J. Cell. Physiol., 213, 88, 10.1002/jcp.21091 · DOI · Paper page
- Tanno, 2007, Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1, J. Biol. Chem., 282, 6823, 10.1074/jbc.M609554200 · DOI · Paper page
- Okamoto, 2006, NF-kappaB and rheumatic diseases, Endocr. Metab. Immune. Disord. Drug Targets, 6, 359, 10.2174/187153006779025685 · DOI
- Li, 2013, Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-kappaB/HIF-1alpha pathway, Mol. Immunol., 53, 227, 10.1016/j.molimm.2012.08.018 · DOI
- Sun, 2017, Rutin attenuates oxidative stress and proinflammatory cytokine level in adjuvant induced rheumatoid arthritis via inhibition of NF-kappaB, Pharmacology, 100, 40, 10.1159/000451027 · doi:10.1159/000451027
- Simmonds, 2008, Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation, Rheumatology, 47, 584, 10.1093/rheumatology/kem298 · DOI · Paper page
- Jeong, 2005, A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity, J. Biol. Chem., 280, 10326, 10.1074/jbc.M412643200 · DOI
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Self-citationmiR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
“Sirt1 is also a target gene of miR-223-3p, and lncRNA-GAS5 is a molecular sponge for miR-223-3p [82, 104].”
Background
Metadata
- Authors
- Li, G., Xia, Z., Liu, Y., Meng, F., Wu, X., Fang, Y., Zhang, C., & Liu, D.
- Affiliations
- Department of Rheumatology, Northern Jiangsu People’s Hospital affiliated to Yangzhou University, Yangzhou City, Jiangsu Province 225000, P.R. China
- Department of Pathology, Northern Jiangsu People’s Hospital affiliated to Yangzhou University, Yangzhou City, Jiangsu Province 225000, P.R. China
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2018-06-21
- Volume
- 38
- Issue
- 3
- ISSN
- 0144-8463
- 1573-4935
- Cited by
- 73
- References
- 4
- Language
- en
- Update notices
- expression_of_concern (2023-08-31)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.